⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for procrit

Every month we try and update this database with for procrit cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
RAPID-2. A Study to Evaluate the Effectiveness of Alternate Dosing of PROCRIT (Epoetin Alfa) in Maintaining Hemoglobin Levels in Patients With Chemotherapy Related AnemiaNCT00495378
Chemotherapy
Cancer
Anemia
epoetin alfa
18 Years - Ortho Biotech Products, L.P.
Procrit Versus No Procrit in Acute Lymphocytic Leukemia, Lymphoblastic Lymphoma, or Burkitt's Undergoing Induction/Consolidation ChemotherapyNCT01099202
Leukemia
Procrit (epoeti...
- M.D. Anderson Cancer Center
PROCRIT (Epoetin Alfa) 60,000 Units Administered Once Every Two Weeks in Anemic Cancer Patients Who Are Not Receiving Chemotherapy or Radiation TherapyNCT00388336
Anemia
Neoplasms
Epoetin Alfa
18 Years - Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDSNCT00656448
Acute Myelogeno...
Myelodysplastic...
Leukemia
Procrit
- M.D. Anderson Cancer Center
A Phase 2 Study to Evaluate the Safety and Effectiveness of Once Weekly or Once Every Two Week Dosing of Epoetin Alfa in Anemic Patients With Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)NCT00446602
Myelodysplastic...
Anemia
Epoetin alfa
18 Years - 99 YearsJohnson & Johnson Pharmaceutical Research & Development, L.L.C.
Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced AnemiaNCT00481624
Anemia
Epoetin Alfa pl...
18 Years - University of Louisville
PROCRIT (Epoetin Alfa) 60,000 Units Administered Once Every Two Weeks in Anemic Cancer Patients Who Are Not Receiving Chemotherapy or Radiation TherapyNCT00388336
Anemia
Neoplasms
Epoetin Alfa
18 Years - Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Procrit Versus Placebo to Determine Efficacy in Pre-Operative Major Surgical Oncology OperationsNCT00624312
Cancer
Procrit
Placebo
18 Years - University of Louisville
Effect of Epoetin Alfa on Hemoglobin, Symptom Distress, and Quality of Life in Patients Receiving ChemotherapyNCT00524407
Chemotherapy
Anemia
Cancer
Epoetin alfa
18 Years - Ortho Biotech Clinical Affairs, L.L.C.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: